FiercePharmaMarketing will now publish every Monday and Wednesday

Publisher
Rebecca Friend

We've seen remarkable growth in our readership since the launch of FiercePharmaMarketing last January. Our email readership now reaches over 30,000 pharma marketing professionals and is one of the Life Sciences group's fastest growing reports. With that growth comes higher expectations from you, the reader, and I am pleased to announce that we will be expanding our coverage to a twice-weekly email report. Starting today, you will receive FiercePharmaMarketing every Monday and Wednesday.

I hope you enjoy our added coverage. We are always interested to hear from you, our readers. Please reach out to let us know how we are doing. -- Rebecca Friend (Twitter | email)

Suggested Articles

Amgen could soon face new competition in the PCSK9 class, but an efficacy boost in treating high-risk heart attack patients could help keep it ahead.

Having already whiffed on one crucial heart failure trial, Novartis is focusing on "profound" data from its Entresto studies in hopes for another go.

Bristol-Myers Squibb and Pfizer's Eliqus has taken the U.S. warfarin alternative market by storm, but can AFib screening amp it up even more?